This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
HCA Healthcare (HCA) Up 43.1% in a Year: Is More Upside Left?
by Zacks Equity Research
Growing revenues, numerous acquisitions and a sturdy financial standing continue to drive HCA Healthcare (HCA).
New to Investing? This 1 Medical Stock Could Be the Perfect Starting Point
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Encompass Health (EHC) Inaugurates New Hospital in Florida
by Zacks Equity Research
Encompass Health (EHC) increases its nationwide inpatient rehabilitation hospital count to 147 with the recently inaugurated 40-bed hospital in St. Augustine, FL.
Acadia Healthcare (ACHC) Eyes Over 600 Bed Additions in 2022
by Zacks Equity Research
Acadia Healthcare (ACHC) has two de novo projects in Chicago and Indio, CA, which are expected to add a total of around 140 beds this year.
Zacks Investment Ideas feature highlights: Tenet Healthcare and HCA Healthcare
by Zacks Equity Research
Tenet Healthcare and HCA Healthcare are included in this blog.
4 Stocks to Watch From the Flourishing Hospital Industry
by Kaibalya Pravo Dey
Rising patient volumes and the growing aging population are driving Zacks Medical-Hospital industry players' profits. HCA Healthcare, Universal Health, Tenet Healthcare and Mednax are poised to benefit from improving operating efficiency.
Hospital Stocks Hovering Near 52-Week Highs Despite Market Volatility
by Bryan Hayes
Hospital Stocks Hovering Near 52-Week Highs Despite Market Volatility
Ensign Group (ENSG) on Buyout Binge for Portfolio Boost
by Zacks Equity Research
Ensign Group (ENSG) buys facilities to expand its presence in Arizona and Texas.
Should Value Investors Pick HCA Healthcare (HCA) Stock Now?
by Zacks Equity Research
Let's see if HCA Healthcare (HCA) stock is a good choice for value-oriented investors right now from multiple angles.
Cigna (CI) Unveils '22 Capital Deployment Plans, Shares Up
by Zacks Equity Research
Cigna's (CI) shares gain on plans to deploy capital via share buybacks and targeted bolt-on acquisitions, which reflect its financial strength.
Encompass Health (EHC) Ties Up to Better Serve Florida Residents
by Zacks Equity Research
Encompass Health (EHC) joins forces with Lee Health in a bid to construct two inpatient rehabilitation hospitals in Southwest Florida and deliver better health outcomes across the region.
HCA Healthcare (HCA) Boasts Earnings & Price Momentum: Should You Buy?
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Mednax's (MD) Q4 Earnings Surpass Estimates, Increase Y/Y
by Zacks Equity Research
Mednax's (MD) Q4 results improve on better revenues and expanded patient volumes.
Humana (HUM) Okays Dividend Hike, Boosts Shareholder Value
by Zacks Equity Research
Humana's (HUM) recent dividend hike highlights its sound financial position and sincere efforts to reward shareholders.
Community Health's (CYH) Earnings Beat, Improve Y/Y in Q4
by Zacks Equity Research
Community Health's (CYH) fourth-quarter 2021 results gain from better revenues.
Why This 1 Medical Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Tenet Healthcare (THC) Q4 Earnings Beat Estimates, Surge Y/Y
by Zacks Equity Research
Tenet Healthcare (THC) Q4 results reflect lower expenses and operational efficiency along with a strong contribution from its Ambulatory Care segment.
New to Investing? This 1 Medical Stock Could Be the Perfect Starting Point
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Ensign Group (ENSG) Buys Facilities to Expand in California
by Zacks Equity Research
Ensign Group (ENSG) further expands in California by purchasing the operations of Arrowhead Springs Healthcare, San Bernardino, CL and Desert Mountain Care Center, Indio, CL.
Encompass Health's (EHC) Q4 Earnings Miss Mark, Increase Y/Y
by Zacks Equity Research
Encompass Health's (EHC) Q4 results reflect escalating costs, partly offset by higher revenues, courtesy of its Inpatient Rehabilitation segment.
Cigna's (CI) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Cigna's (CI) fourth-quarter earnings results likely to reflect higher revenues and solid segmental contributions.
HCA Healthcare's (HCA) Q4 Earnings Miss Mark, Improve Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) Q4 results reflect higher expenses, partly offset by better revenues owing to improved patient volumes.
HCA Healthcare (HCA) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of -2.86% and 2.25%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Why HCA Healthcare (HCA) Might Surprise This Earnings Season
by Zacks Equity Research
HCA Healthcare (HCA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Is a Beat in Store for HCA Healthcare's (HCA) Q4 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter earnings are likely to have gained from rising admissions and higher revenues.